IVM Survey Among Reproductive Medicine Specialists

IVM Clinical Trial

Official title:

Survey of Fertility Specialists' Knowledge of, Experience With, and Attitudes Toward the Use of in Vitro Maturation of Oocytes in Reproductive Medicine

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04488211
• Other study ID #: IVM Survey V2 04062020
• Status: Completed
• Start date: July 30, 2020
• Est. completion date: December 31, 2020

Study information

• Verified date: June 2020
• Source: Universitair Ziekenhuis Brussel
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Although IVM as a laboratory technology in reproductive medicine has existed for many decades, there is a lack of well-designed studies comparing the efficiency and the patient satisfaction related to IVM as compared to standard ovarian stimulation for IVF. In view of this, and in order to identify unmet needs of fertility specialists with regard to the application of IVM, the investigator developed the idea of a worldwide web-based survey analysis of fertility specialists' insights and experiences regarding IVM.

Description:

The IVM survey will be structured as a series of open questions and multiple-choice questions. In most of the questions, a single answer will be required by participants. A small number of questions will allow multiple answers. The survey will be web-based. Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic. Clinics will be identified based on whether they have worked with IVM previously but stopped, and clinics with appropriate size to offer IVM competence. When no response is obtained from selected fertility specialists, e-mails will be sent to affiliated colleagues working at the same fertility clinic. When analyzing the survey results, care will be taken to analyse the responses per fertility clinic, as responses from different fertility specialists working in the same fertility clinic should be avoided. Results will be analysed using a method that assigns equal weight per clinic and a method that weights clinic responses based on treatment volume (number of IVF cycles).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: December 31, 2020
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• IVF clinics that have worked with IVM previously but stopped

• clinics with appropriate size to offer IVM

Related Conditions & MeSH terms

• IVM

Intervention

Other:
• Survey
The IVM survey will be structured as a series of open questions and multiple-choice questions.

Locations

Country	Name	City	State
Belgium	Universitair Ziekenhuis Brussel	Brussel

Sponsors (2)

Lead Sponsor	Collaborator
Universitair Ziekenhuis Brussel	CooperSurgical Inc.

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Name of the measurement: Application of in vitro maturation (IVM) of oocytes as a laboratory tool	Measurement tool: questionnaire; unit of measure: % of respondents who use oocyte in vitro maturation in the laboratory;	1 month
Primary	Name of the measurement: Appreciation of IVM as a laboratory technique	Measurement tool: questionnaire; unit of measure: % of respondents who believe there is a role for IVM in the ART (assisted reproductive technology ) clinic	1 month
Secondary	Name of the measurement: Annual number of egg retrievals for IVM	Measurement tool: questionnaire; unit of measure: number	1 month